We are live on
!
Find out more
ALDR
Alder Biopharmaceuticals
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
142 hedge funds and large institutions have $1.1B invested in Alder Biopharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 52 increasing their positions, 47 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
29% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 14
11% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 47
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
1% less capital invested
Capital invested by funds: $1.11B → $1.1B (-$13.5M)
2% less funds holding
Funds holding: 145 → 142 (-3)
16% less call options, than puts
Call options by funds: $742K | Put options by funds: $882K
Holders
142
Holders Change
-3
Holders Change %
-2.07%
% of All Funds
3.53%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
18
Increased
52
Reduced
47
Closed
14
Calls
$742K
Puts
$882K
Net Calls
-$140K
Net Calls Change
-$2.28M
Top Buyers
| 1 |
BlackRock
New York
|
+$87.2M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$21.9M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$9.56M |
| 4 |
AG
Artal Group
Luxembourg
|
+$6.64M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$5.56M |
